1h Free Analyst Time
Hepatitis Viruses Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019Speak directly to the analyst to clarify any post sales queries you may have.
Summary
The Publisher's Medical Devices sector report, “Hepatitis Viruses Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Viruses Rapid Tests & Point of Care (POC) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses Rapid Tests & Point of Care (POC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hepatitis Viruses Rapid Tests & Point of Care (POC) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & Point of Care (POC) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & Point of Care (POC) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
3 Products under Development
4 Hepatitis Viruses Rapid Tests & Point of Care (POC) - Pipeline Products under Development by Companies
5 Hepatitis Viruses Rapid Tests & Point of Care (POC) Companies and Product Overview
6 Hepatitis Viruses Rapid Tests & Point of Care (POC) - Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Diagnostics
- Access Bio Inc
- Akers Biosciences Inc
- Alere Inc
- Atomo Diagnostics Pty Ltd
- Biocartis Group NV
- bioLytical Laboratories Inc
- Biosurfit, SA
- Biotech Consortium India Ltd
- Biotech Resources Pty Ltd
- Blink AG
- Cepheid
- Chembio Diagnostic Systems Inc
- ChipCare Corp
- Co-Diagnostics HBDC, Inc.
- Co-Diagnostics Inc
- Correlia Biosystems, Inc.
- CrossLife Technologies Inc
- Daktari Diagnostics, Inc.
- DCN Diagnostics
- Diagnostics For All Inc
- Diagnostics for the Real World Limited
- DxDiscovery, Inc.
- Fast Track Diagnostics Ltd.
- genedrive plc
- Group K Diagnostics
- HLL Lifecare Ltd
- ImmunoScience Inc
- MedMira Inc
- Micronics Inc
- Mologic Ltd
- NanoComposix Inc
- NanoRepro AG
- NOWDiagnostics Inc
- Quidel Corp
- Sedia Biosciences Corp
- SLS Cell Cure Technologies Pty Ltd
- University of California Irvine
- Wave 80 Biosciences Inc
- Xagenic Inc
